The mechanisms of resistance include secondary mutation of targeted protein (226), activation of alternative pathways (227), aberrance of the downstream pathways (228), impairment of the EGFR-TKIs-mediated apoptosis pathway (229), ATP binding cassette (ABC) transporter effusion (230), etc. At present, immunotherapy is a very promising approach for cancer treatment. Here, EGFR is linked to cancer.